文献速递糖尿病肥胖与代谢综合征

2型糖尿病缓解对长期健康结局的影响:Look AHEAD研究结果

Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study.
PubMed 文献 · Diabetologia · 2024-01-18

Look AHEAD多中心随机对照试验比较12年强化生活方式干预与糖尿病支持教育,在4402名和4132名参与者中分别分析糖尿病缓解与CKD、CVD发生率的关系。随访期间出现任何缓解者CKD风险降低33%(HR 0.67;95%CI 0.52,0.87)、复合CVD风险降低40%(HR 0.60;95%CI 0.47,0.79),缓解持续时间越长风险降低幅度越大。

要点

  • 随访期间出现任何糖尿病缓解者CKD风险显著低于未缓解者(HR 0.67;95%CI 0.52,0.87)。
  • 随访期间出现任何糖尿病缓解者复合CVD风险显著低于未缓解者(HR 0.60;95%CI 0.47,0.79)。
  • 缓解持续时间越长,CKD与CVD风险降低幅度越大。

核心结论

  • 有证据表明2型糖尿病参与者出现缓解者,其CKD和CVD发生率分别显著低于未达到缓解的参与者。
  • 这种关联可能受基线后体重、体能、HbA1c和LDL-胆固醇改善的影响。

研究设计与样本

  • Look AHEAD研究为多中心随机对照试验,比较12年强化生活方式干预与糖尿病支持教育对CVD及其他长期健康状况的影响。
  • 分别基于4402名和4132名参与者的糖尿病缓解获得情况及持续时间,比较CVD和CKD发生率。
  • 参与者58%为女性,平均年龄59岁,糖尿病病程6年,BMI 35.8 kg/m2。
  • 缓解采用流行病学定义:某一时点未使用降糖药物且HbA1c <48 mmol/mol(6.5%)。
  • CKD高风险或极高风险按KDIGO标准定义;CVD发生定义为非致死性急性心肌梗死、卒中、因心绞痛住院或CVD死亡的任何发生。

主要发现

  • 随访期间有证据表明出现任何缓解的参与者,与未缓解者相比,CKD发生率降低33%(HR 0.67;95%CI 0.52,0.87)。
  • 随访期间有证据表明出现任何缓解的参与者,与未缓解者相比,复合CVD指标发生率降低40%(HR 0.60;95%CI 0.47,0.79)。
  • 上述多变量分析校正了HbA1c、血压、血脂水平、CVD史、糖尿病病程和干预组。
  • 缓解持续时间较长的参与者风险降低幅度最大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We examined the association of attainment of diabetes remission in the context of a 12 year intensive lifestyle intervention with subsequent incidence of chronic kidney disease (CKD) and CVD. METHODS: The Look AHEAD study was a multi-centre RCT comparing the effect of a 12 year intensive lifestyle intervention with that of diabetes support and education on CVD and other long-term health conditions. We compared the incidence of CVD and CKD among 4402 and 4132 participants, respectively, based on achievement and duration of diabetes remission. Participants were 58% female, and had a mean age of 59 years, a duration of diabetes of 6 year and BMI of 35.8 kg/m2. We applied an epidemiological definition of remission: taking no diabetes medications and having HbA1c <48 mmol/mol (6.5%) at a single point in time. We defined high-risk or very high-risk CKD based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, and CVD incidence as any occurrence of non-fatal acute myocardial infarction, stroke, admission for angina or CVD death. RESULTS: Participants with evidence of any remission during follow-up had a 33% lower rate of CKD (HR 0.67; 95% CI 0.52, 0.87) and a 40% lower rate of the composite CVD measure (HR 0.60; 95% CI 0.47, 0.79) in multivariate analyses adjusting for HbA1c, BP, lipid levels, CVD history, diabetes duration and intervention arm, compared with participants without remission. The magnitude of risk reduction was greatest for participants with evidence of longer-term remission. CONCLUSIONS/INTERPRETATION: Participants with type 2 diabetes with evidence of remission had a substantially lower incidence of CKD and CVD, respectively, compared with participants who did not achieve remission. This association may be affected by post-baseline improvements in weight, fitness, HbA1c and LDL-cholesterol. TRIAL REGISTRATION: ClinicalTrials.gov NCT00017953 DATA AVAILABILITY: https://repository.niddk.nih.gov/studies/look-ahead/.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Gregg EW, Chen H, Bancks MP, et al. Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study. Diabetologia. 2024. PMID: 38233592. doi:10.1007/s00125-023-06048-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。